LMLilian Mantziari

Lilian Mantziari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Lilian Mantziari has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Somatostatin analogue scintigraphy in a patient with viral myocarditis.

    by Efstratios Moralidis, Lilian Mantziari, George Gerasimou, Ioannis H Styliadis, Anna Gotzamani-Psarrakou

    Myocarditis may present clinically with a wide range of manifestations and often remains unrecognized. The diagnosis of myocarditis traditionally has been based on histological findings, but endomyocardial biopsy has a low sensitivity and clinicians are reluctant to proceed with an invasive diagnostic technique. Among newer diagnostic approaches, cardiac magnetic resonance imaging has gained acceptance as an efficient noninvasive tool to determine myocardial inflammation. In this context, imaging with radiolabeled somatostatin analogues could also be relevant because of their ability to delineate inflammatory sites. In conclusion, a case is presented in which somatostatin receptor imaging of the myocardium with (99m)Tc-depreotide tomography was used in the assessment of viral myocarditis.


  • Practice patterns of cardiologists, general practitioners, and internists for managing supraventricular tachycardias in Greece

    by Vassilios P. Vassilikos, Lilian Mantziari, Christos A. Goudis, Stelios Paraskevaidis, Georgios Dakos, Georgios Stavropoulos, Georgios Giannoglou, Georgios Efthimiadis, Sotirios Mochlas, Georgios Parcharidis, et al.

    Objectives Supraventricular tachycardias (SVT) often lead to emergency room and primary care visits. Not only cardiologists, but also general practitioners (GPs) and internists are involved to an increasing extent in the acute and long-term management of SVT. We aimed to explore the differences between practice patterns of cardiologists and noncardiologists with regard to SVT management in Greece. Methods A cross-sectional questionnaire survey was conducted among 250 cardiologists and 250 GPs/internists from various areas across Greece. Results A response rate of 61.8% was obtained. Vagal maneuvers were the initial therapeutic approach for SVT termination; however, 22% of noncardiologists would rather start with an antiarrhythmic drug. Adenosine was the most popular drug for SVT termination, but the GPs/internists would use it less often than the cardiologists (67 vs. 86%, PP<0.005). With regard to the long-term management of SVT, the GPs/internists would prescribe antiarrhythmic drugs earlier than the cardiologists, and seem to be less familiar with the indications for the electrophysiological testing and ablation. Conclusion Significant differences in practice patterns exist in Greece with regard to SVT management between cardiologists and noncardiologists. The GPs/internists seem to rely more on antiarrhythmic drugs and tend to underestimate the role of ablation therapy for the long-term management of SVT.


  • Open Access

    Effects of renin-angiotensin system inhibition on right ventricular function in patients with mild essential hypertension

    by Georgios Pechlivanidis, Lilian Mantziari, Georgios Giannakoulas, Hariklia Dimitroula, Haralambos Styliadis, Haralambos Karvounis, Ioannis H Styliadis, Georgios Parharidis

    Introduction: Systemic hypertension is known to affect both left and right ventricular (RV) function. Little is known about the effect of the renin—angiotensin system (RAS) inhibition on global RV function in patients with essential hypertension. Materials and methods: Forty patients (17 male, mean age 47 ± 10 years) with mild hypertension free of cardiovascular disease were assessed by echocardiography at baseline and after nine months of antihypertensive treatment with RAS inhibitors. Tissue Doppler imaging derived myocardial performance index (MPI) of the left and right ventricle was used as an index of global ventricular function. Results: Both left ventricular (LV) and RV MPI were increased at baseline and were reduced after treatment (LV MPI reduced from 0.42 ± 0.06 to 0.39 ± 0.05, p < 0.001 and RV MPI was reduced from 0.34 ± 0.06 to 0.32 ± 0.05, p < 0.005). There was a positive correlation between mitral and tricuspid E/A ratio both at baseline and at month nine after treatment (r = 0.661, p < 0.001 and r = 0.503, p < 0.005 respectively). LV mass index and interventricular septum thickness were decreased after treatment. No correlation was found between MPI improvement and blood pressure reduction. Conclusions: RAS inhibition in patients with mild hypertension results in an improvement of RV global function which is unrelated to the reduction in blood pressure.


    • 21 December 2010
      • Vol. 51  (6) , 552-7

    An interesting case of cardiac amyloidosis initially diagnosed as hypertrophic cardiomyopathy.

    by Amalia Boufidou, Lilian Mantziari, Stelios Paraskevaidis, Haralambos Karvounis, Eleni Nenopoulou, Maria-Eleni Manthou, Ioannis H Styliadis, Georgios Parcharidis

    Cardiac involvement occurs frequently in primary amyloidosis and is associated with heart failure hospitalizations and poor survival. The initial presentation of the disease may be misleading, resulting in under-diagnosis of cardiac amyloidosis and late initiation of treatment. We present a case of cardiac amyloidosis initially misdiagnosed as hypertrophic cardiomyopathy and we discuss the key findings of the disease along with the latest evidence regarding the management and prognosis of cardiac amyloidosis.